Ribesh Shrestha (@freshribesh) 's Twitter Profile
Ribesh Shrestha

@freshribesh

Baylor 15 • TCOM 21 • UT Health San Antonio IM • Baylor S&W Cardiology🫀

ID: 169082851

calendar_today21-07-2010 14:13:33

191 Tweet

892 Followers

1,1K Following

Global Cardiology University (@cardiologyuniv) 's Twitter Profile Photo

Our team is dedicated to achieve our mission of #educating, #empowering and #connecting medical professionals worldwide! #GCU #Cardiology #CardioTwitter #Meded 🫀💻

Our team is dedicated to achieve our mission of #educating, #empowering and #connecting medical professionals worldwide! #GCU #Cardiology #CardioTwitter #Meded 🫀💻
Nandan Anavekar (@nandananavekar) 's Twitter Profile Photo

GCU is working towards a vision of reaching learners and educators far and wide. Honored to participate in their activities. Thank you for the chance

Sanjiv J. Shah, MD (@hfpef) 's Twitter Profile Photo

1/ #HFpEF treatment algorithm #tweetorial. This is the algorithm I currently use to treat HFpEF based on evidence we have thus far and my anecdotal experience treating patients over the past 16 years in the NM Cardiovascular HFpEF Clinic.

Ribesh Shrestha (@freshribesh) 's Twitter Profile Photo

We had a great discussion about the historical precedence of 160/110 to start treat hypertension in pregnancy due to concern of growth restrictions, but new results from the CHAP trial should encourage us to change the paradigm #HighRiskPreg23

We had a great discussion about the historical precedence of 160/110 to start treat hypertension in pregnancy due to concern of growth restrictions, but new results from the CHAP trial should encourage us to change the paradigm #HighRiskPreg23
Ankur Kalra (@ankurkalramd) 's Twitter Profile Photo

Parallax Ep 93 with Drs. Anavekar, Kashou and Ellauzi: Empowering Learners in Cardiovascular Education through the Global Cardiology University. Have a listen: podcasts.apple.com/us/podcast/par…

Parallax Ep 93 with Drs. Anavekar, Kashou and Ellauzi: Empowering Learners in Cardiovascular Education through the Global Cardiology University. Have a listen: podcasts.apple.com/us/podcast/par…
Rama Ellauzi (@ellauzirama) 's Twitter Profile Photo

💥 🔊💥 Exciting times as we delve into cardiovascular education on Ep 93 of Parallax with Ankur Kalra, alongside Drs. Anavekar & Kashou. 🚨Tune in for an insightful conversation!!!! 🚨#Podcast #MedEd #CardioEd Global Cardiology University 🫀 🎧: podcasts.apple.com/us/podcast/par…

💥 🔊💥
Exciting times as we delve into cardiovascular education on Ep 93 of Parallax with <a href="/AnkurKalraMD/">Ankur Kalra</a>, alongside Drs. Anavekar &amp; Kashou.  

🚨Tune in for an insightful conversation!!!! 🚨#Podcast #MedEd #CardioEd  <a href="/CardiologyUniv/">Global Cardiology University</a> 🫀

🎧: podcasts.apple.com/us/podcast/par…
Rachel Goodman (@goodmra1) 's Twitter Profile Photo

1/28 You are the resident on CICU. A patient arrives with an intra-aortic balloon pump (IABP). What is it? How does it work? How do you troubleshoot? It's ⏰ for a CardioNerds tweetorial! AKA things I've gotten wrong on rounds so you don't have to. First up: the basics

1/28
You are the resident on CICU.  A patient arrives with an intra-aortic balloon pump (IABP).  What is it?  How does it work?  How do you troubleshoot?

It's ⏰ for a <a href="/CardioNerds/">CardioNerds</a> tweetorial!
AKA things I've gotten wrong on rounds so you don't have to.

First up: the basics
Justin Haloot (@drhaloot) 's Twitter Profile Photo

If you're ever asked to interrogate a pacemaker, here's a great way to remember a systematic approach and not miss anything, thanks for the tip and lessons from BCM Cardiology @jerin3590 (1/9) #CardioTwitter #Epeeps

If you're ever asked to interrogate a pacemaker, here's a great way to remember a systematic approach and not miss anything, thanks for the tip and lessons from <a href="/BCMHeart/">BCM Cardiology</a> @jerin3590 (1/9) #CardioTwitter #Epeeps
Ahmed Teebi, MD MPH🗝️ (@teebi_md) 's Twitter Profile Photo

⭐️Groundbreaking! The AZALEA-TIMI 71 trial randomizing Abelacimab (factor XI/XIa inhibitor) for stroke prevention in AF➡️stopped due to overwhelming efficacy! ✅Abelacimab vs Rivarixiban in AF patients ✅Randomized 1,200 patients from 90 countries ✅Abelacimab lowered

⭐️Groundbreaking! The AZALEA-TIMI 71 trial randomizing Abelacimab (factor XI/XIa inhibitor) for stroke prevention in AF➡️stopped due to overwhelming efficacy!

✅Abelacimab vs Rivarixiban in AF patients
✅Randomized 1,200 patients from 90 countries
✅Abelacimab lowered
Justin Haloot (@drhaloot) 's Twitter Profile Photo

🫀FITs, the ACC EP Council wants your opinion on the current state of 🫀 & EP⚡️ Training! Please take a few minutes to fill out this anonymous survey We want to talk about it at ACC25 #ACC #ACC25 #ACCFIT Please share with 🫀 Fellows! redcap.link/CVDCCEPSurvey